-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LBqOA0fkXDDQxAfHUl76MjsH0MG5sv7PIg7lzg7yG6d4IQfyzYUytcJmZbQf9cOE
 +tn5ttbmyux6bjwveqtX8w==

<SEC-DOCUMENT>0000912057-01-506418.txt : 20010409
<SEC-HEADER>0000912057-01-506418.hdr.sgml : 20010409
ACCESSION NUMBER:		0000912057-01-506418
CONFORMED SUBMISSION TYPE:	10KSB
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20001231
FILED AS OF DATE:		20010402

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADVANCED BIOTHERAPY INC
		CENTRAL INDEX KEY:			0000791833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10KSB
		SEC ACT:		
		SEC FILE NUMBER:	000-26323
		FILM NUMBER:		1591205

	BUSINESS ADDRESS:	
		STREET 1:		6355 TOPANGA CANYON BLVD
		STREET 2:		SUITE 510
		CITY:			WOODLAND HILLS
		STATE:			CA
		ZIP:			91367
		BUSINESS PHONE:		8188833956

	MAIL ADDRESS:	
		STREET 1:		6355 TOPANGA CANYON BLVD
		STREET 2:		SUITE 510
		CITY:			WOODLAND HILLS
		STATE:			CA
		ZIP:			91367

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED BIOTHERAPY CONCEPTS INC
		DATE OF NAME CHANGE:	19990524
</SEC-HEADER>
<DOCUMENT>
<TYPE>10KSB
<SEQUENCE>1
<FILENAME>a2043353z10ksb.txt
<DESCRIPTION>10KSB
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>2
<FILENAME>a2043353zex-10_3.txt
<DESCRIPTION>EXHIBIT 10.3
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>3
<FILENAME>a2043353zex-10_4.txt
<DESCRIPTION>EXHIBIT 10.4
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>4
<FILENAME>a2043353zex-10_6.txt
<DESCRIPTION>EXHIBIT 10.6
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>5
<FILENAME>a2043353zex-10_7.txt
<DESCRIPTION>EXHIBIT 10.7
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>a2043353zex-23_1.txt
<DESCRIPTION>EXHIBIT 23.1
</DOCUMENT>
</SUBMISSION>